Kedrion SpA - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Kedrion SpA (Kedrion) collects and fractionates blood plasma to develop, produce and distribute plasma-derived therapies. The companys products are used for the treatment of rare and serious disorders such as hemophilia, immune deficiency and neurological disorders. It also offers products for the treatment of orphan diseases. Kedrion also offers contract manufacturing services, technology transfer services and biological safety center services. The company works in partnership with Italian National Health Service to achieve self-sufficiency in plasma-derived therapies. It has manufacturing plants in Italy, Hungary and the US. The company has operational presence in Asia, Europe, North America and South America. Kedrion is headquartered in Barga, Lucca, Italy.

Kedrion SpA - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
Kedrion SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kedrion SpA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Kedrion SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kedrion SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Kedrion SpA, Medical Devices Deals, 2012 to YTD 2018 10
Kedrion SpA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Kedrion SpA, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Kedrion Acquires RhoGAM Line Of Products From Ortho-Clinical Diagnostics 12
Partnerships 13
National Immunobiological, Pharmstandard and Kedrion Biopharma form Joint Venture 13
Biotest Pharma Enters into Distribution Agreement with Kedrion Biopharma 14
Licensing Agreements 15
United Biotech Enters into Licensing Agreement with Kedrion 15
Debt Offering 16
Kedrion Raises USD397 Million in Public Offering of 3% Bonds Due 2022 16
Kedrion Raises USD514 Million in Private Placement of Bonds 17
Acquisition 18
Kedrion Completes Acquisition Of Somerset Labs From Ortho-Clinical Diagnostics 18
Fondo Strategico Italiano Acquires 18.6% Stake In Kedrion From Sestant For US$188 Million 19
Kedrion SpA - Key Competitors 20
Kedrion SpA - Key Employees 21
Kedrion SpA - Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List Of Tables


Kedrion SpA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Kedrion SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kedrion SpA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Kedrion SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kedrion SpA, Deals By Therapy Area, 2012 to YTD 2018 8
Kedrion SpA, Medical Devices Deals, 2012 to YTD 2018 10
Kedrion SpA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Kedrion Acquires RhoGAM Line Of Products From Ortho-Clinical Diagnostics 12
National Immunobiological, Pharmstandard and Kedrion Biopharma form Joint Venture 13
Biotest Pharma Enters into Distribution Agreement with Kedrion Biopharma 14
United Biotech Enters into Licensing Agreement with Kedrion 15
Kedrion Raises USD397 Million in Public Offering of 3% Bonds Due 2022 16
Kedrion Raises USD514 Million in Private Placement of Bonds 17
Kedrion Completes Acquisition Of Somerset Labs From Ortho-Clinical Diagnostics 18
Fondo Strategico Italiano Acquires 18.6% Stake In Kedrion From Sestant For US$188 Million 19
Kedrion SpA, Key Competitors 20
Kedrion SpA, Key Employees 21
Kedrion SpA, Subsidiaries 22

List Of Figures


Kedrion SpA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Kedrion SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Kedrion SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Kedrion SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Kedrion SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kedrion SpA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Kedrion SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kedrion SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Kedrion SpA, Medical Devices Deals, 2012 to YTD 2018 10

Kedrion SpA - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Kedrion SpA (Kedrion) collects and fractionates blood plasma to develop, produce and distribute plasma-derived therapies. The companys products are used for the treatment of rare and serious disorders such as

USD 250 View Report

Kedrion SpA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Kedrion SpA (Kedrion) collects and fractionates blood plasma to develop, produce and distribute plasma-derived therapies. The companys products are used for the treatment of rare and serious disorders such as

USD 250 View Report

Edison SpA - Power Plants and SWOT Analysis, 2018 Update

Edison SpA - Power Plants and SWOT Analysis, 2018 UpdateThe report contains a detailed description of the power generation companys business operations, history, corporate strategy, and business structure. This report

USD 1000 View Report

Versalis SpA - Strategic SWOT Analysis Review

Versalis SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on

USD 125 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available